Tenaya Therapeutics (TNYA) Other Working Capital Changes (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Other Working Capital Changes of $10.4 million for Q1 2026, up 1592.4% year-over-year from $614631.6 in Q1 2025, and up 1592.4% quarter-over-quarter from -$697000.0 in Q4 2025.
Tenaya Therapeutics (TNYA) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 1592.4% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $8.3 million (up 2204.99% YoY), while the FY2025 annual figure was -$2.8 million, changed N/A from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $10.4 million, up from -$697000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $10.4 million in Q1 2026, with the low at -$3.1 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$697000.0 (2025), against an average of $265764.7.
- The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes tumbled 379.82% in 2022, then soared 1592.4% in 2026.
- Tenaya Therapeutics' Other Working Capital Changes stood at -$3.1 million in 2022, then soared by 197.95% to $3.1 million in 2023, then advanced by 4.32% to $3.2 million in 2024, then sank by 121.86% to -$697000.0 in 2025, then jumped by 1592.4% to $10.4 million in 2026.
- Business Quant data shows TNYA's Other Working Capital Changes at $10.4 million in Q1 2026, -$697000.0 in Q4 2025, and -$683000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -739,000.00 |
| Jun 30, 2026 | -739,000.00 |
| Jun 30, 2026 | -739,000.00 |
| Mar 31, 2026 | 10.40 Mn |
| Mar 31, 2026 | 10.40 Mn |
| Mar 31, 2026 | 10.40 Mn |
| Dec 31, 2025 | -697,000.00 |
| Dec 31, 2025 | -697,000.00 |
| Dec 31, 2025 | -697,000.00 |
| Sep 30, 2025 | -683,000.00 |
| Sep 30, 2025 | -683,000.00 |
| Sep 30, 2025 | -683,000.00 |
| Jun 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -701,000.00 |
| Mar 31, 2025 | -697,000.00 |
| Mar 31, 2025 | -697,000.00 |
| Mar 31, 2025 | -697,000.00 |
| Dec 31, 2024 | 3.19 Mn |
| Dec 31, 2024 | 3.19 Mn |